Skip to main content

Oxford Cannabinoid Technologies "proceeding forward as planned" after review meeting

Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP, OTCQB:OCTHF) CEO Clarissa Sowemimo-Coker speaks to Proactive after announcing that a Research Ethics Committee (REC) review meeting for its lead programme OCT461201 has now taken place. Sowemimo-Coker says the company is "proceeding forward as planned" and has "hit the ground running" in 2023.

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

Recent Quotes

View More
Symbol Price Change (%)
AMZN  222.95
+0.39 (0.18%)
AAPL  273.84
-0.77 (-0.28%)
AMD  198.17
-11.00 (-5.26%)
BAC  54.59
-0.22 (-0.39%)
GOOG  298.36
-9.37 (-3.04%)
META  653.06
-4.09 (-0.62%)
MSFT  479.03
+2.64 (0.55%)
NVDA  170.93
-6.79 (-3.82%)
ORCL  178.95
-9.70 (-5.14%)
TSLA  468.00
-21.88 (-4.47%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.